Catalyst Wire Dossier Catalyst Wire Dossier

TV-45070

TV-45070 · Teva Branded Pharmaceutical Products R&D, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TV-45070, covering 2018-10-23 to 2018-10-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Topically Applied TV-45070 (Ointment) in Participants With Primary Osteoarthritis (OA) Affecting a Single Knee [Phase 2]

See pricing